DATA GRAPHICS | Finance
Data Byte: IPO enthusiasm gives Dyne first-day pop as queue continues to grow
September 18, 2020 1:53 AM UTC
Dyne Therapeutics’ 26% pop on its first day of trading Thursday highlights continuing investor appetite for preclinical IPOs.
The company raised $232.8 million through the sale of 12.3 million shares at $19 in the upsized offering; its aftermarket gains of $4.90 to $23.90 lifted its valuation to nearly $1 billion...